Advances in the development of an early detection kit for bowel cancer

September 25, 2012
DNA microarray slide before use. Photograph: UPM.

Rubén Armañanzas and Pedro Larrañaga, researchers of the Computational Intelligence Group at the Universidad Politécnica de Madrid's Facultad de Informática have used advanced statistical and data mining techniques to filter information about the activity of over 22,000 genes and have managed to separate tumoural from non-tumoural samples with a precision of 94.45%.

This is the UPM's contribution to a joint effort among several Spanish institutions to assemble a genetic test for early detection. The goal of the study is to develop a low-cost device integrating biomarker measurement and mathematical models.

At present, detection is primarily based on the result of biopsies of polyps identified during a colonoscopy. However, this is a highly invasive technique that often comes too late.

The study started with the analysis of the genetic activity of over 22,000 genes simultaneously using . All this information was filtered using advanced statistical and high-dimensional .

This led to the identification of a small subset of genes that behaved differently in tumoural and non-tumoural samples. A classifier or diagnostic predictor can be built by combining the expression patterns using complex mathematical models.

94.45% precision

Based on the gene panel, known in the technical jargon as biomarkers, the mathematical models are able to classify a new set of tumoural or non-tumoural samples with a precision of 94.45%.

As mentioned earlier, the final goal of the study is to be able to develop a low-cost device integrating the measurement of the biomarker panel and mathematical models. Its use in clinical practice could be helpful for early bowel , while at the same time reducing costs and inconvenience to patients.

The project kicked off in 2005 and has been developed in several phases. It has involved patient recruitment and informed consent, DNA microarray-based laboratory testing, computational analysis using machine learning techniques and validation.

The results have been published in BMC Cancer. Despite the promising results, population studies are now required to further validate the findings. These studies are now under way and are expected to return new results in the coming years.

Explore further: Gene expression changes in nasal cells may help identify lung cancer in earliest stages

More information: Garcia-Bilbao, A; Armananzas, R; Ispizua, Z; Calvo, B; Alonso-Varona, A; Inza, I; Larranaga, P; Lopez-Vivanco, G; Suarez-Merino, B; Betanzos, M. Identification of a biomarker panel for colorectal cancer diagnosis, BMC CANCER, 12 10.1186/1471-2407-12-43 JAN 26 2012

Related Stories

Gene expression changes in nasal cells may help identify lung cancer in earliest stages

May 15, 2011
A simple, minimally-invasive technique using cells from the interior of the nose could help clinicians detect lung cancer in its earliest – and most treatable – stages, according to a study conducted by researchers ...

Potential for earlier diagnosis of ovarian cancer

January 25, 2012
(Medical Xpress) -- Australian scientists have identified biochemical changes that commonly occur in the DNA of women with ovarian cancer, which may help diagnose the cancer at an earlier stage in the future.

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.